Valuation: Novonesis A/S

Market Cap 214B 31.96B 28.67B 26.2B 23.92B 45.06B 3,005B 46.48B 316B 126B 1,603B 120B 117B 5,061B P/E 2026 *
39.1x
P/E 2027 * 33.4x
Enterprise Value 235B 35.02B 31.41B 28.71B 26.2B 49.37B 3,292B 50.93B 346B 138B 1,757B 131B 129B 5,545B EV / Sales 2026 *
7.03x
EV / Sales 2027 * 6.49x
Free-Float
74.08%
Yield 2026 *
1.58%
Yield 2027 * 1.77%
1 day-4.15%
1 week-0.43%
Current month-0.43%
1 month+6.73%
3 months+8.26%
6 months+18.53%
Current year+12.80%
1 week 448
Extreme 448
484.7
1 month 426.8
Extreme 426.8
484.7
Current year 336.8
Extreme 336.8
484.7
1 year 336.8
Extreme 336.8
484.7
3 years 336.8
Extreme 336.8
489.4
5 years 274.6
Extreme 274.6
545.8
10 years 220.7
Extreme 220.7
545.8
Date Insider Type Main position Quantity % Market Cap. Importance
21/11/25 Buy

Director

2,500 0.0006%
21/11/25 Buy

Director

2,500 0.0006%
07/11/25 Buy

Head of Human Resources

380 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-4.15%-0.43%+10.84%+36.05% 33.57B
-1.68%-0.76%+18.82%+72.34% 85.78B
-1.24%+2.04%+22.29%+33.44% 46.49B
-1.85%+3.43%+21.60%-17.67% 37.15B
-0.88%+3.84%+16.20%+22.74% 35.77B
-5.90%-6.14%-3.58%+14.30% 26.45B
-1.28%+0.65%+57.86%+40.02% 24.66B
+1.10%+4.62%+24.75%-29.77% 19.21B
+2.06%+5.25%+24.31%+19.93% 16.1B
-1.65%+3.57%+34.52%+2.97% 15.04B
Average -1.55%+3.87%+22.76%+19.44% 34.02B
Weighted average by Cap. -1.76%+3.10%+20.91%+30.23%

Financials

2026 *2027 *
Net sales 33.39B 4.98B 4.47B 4.08B 3.73B 7.02B 468B 7.24B 49.21B 19.62B 250B 18.69B 18.29B 789B 35.96B 5.36B 4.81B 4.4B 4.01B 7.56B 504B 7.8B 52.99B 21.13B 269B 20.13B 19.7B 849B
Net income 5.44B 811M 727M 665M 607M 1.14B 76.23B 1.18B 8.01B 3.19B 40.68B 3.04B 2.98B 128B 6.38B 952M 854M 781M 712M 1.34B 89.51B 1.38B 9.41B 3.75B 47.76B 3.57B 3.5B 151B
Net Debt 20.5B 3.06B 2.74B 2.51B 2.29B 4.31B 287B 4.45B 30.21B 12.05B 153B 11.48B 11.23B 484B 18.98B 2.83B 2.54B 2.32B 2.12B 3.99B 266B 4.12B 27.97B 11.15B 142B 10.62B 10.4B 448B
Projected Income Statement - Annual - Novonesis A/S
Logo Novonesis A/S
Novonesis A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - agriculture, bioenergy and animal feed industries (35.8%); - food industries (33%); - cleaning and household care products industries (19.3%); - human nutritional health industries (11.9%). Net sales are geographically distributed as follows: Denmark (1.1%), Europe/Middle East/Africa (34.6%), North America (32%), Asia/Pacific (18.7%), and Latin America (13.6%).
Employees
11,098
Date Price Change Volume
06/11/26 DKK 460.00 -4.15% 905,267
05/11/26 DKK 479.90 +4.51% 1,112,390
04/11/26 DKK 459.20 +0.33% 1,217,963
03/11/26 DKK 457.70 -0.82% 551,999
02/11/26 DKK 461.50 -0.11% 604,888
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Novonesis A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
460.00DKK
Average target price
501.00DKK
Spread / Average Target
+8.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Novonesis A/S
  1. Stock Market
  2. Stocks
  3. NSIS B Stock